相关实验视频
Updated: Jul 17, 2025

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
在Graves的轨道病变中,每周高剂量甲基普雷迪尼索隆治疗12周期间,骨的循环减少,骨结构得到改善
Torben Harsløf1,2, Rawan Hikmet3, Eva Ebbehøj3
1Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark. torbhars@rm.dk.
对于格雷夫斯轨道病的每周甲基普雷迪尼索隆减少了骨的循环和多孔性. 骨矿物质密度在24周内增加,表明这种治疗对骨健康是安全的.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 眼科医生 眼科 眼科
背景情况:
- 格雷夫斯的轨道病症通常用静脉注射甲基prednisolone治疗.
- 这种治疗可能会对骨质和骨结构产生负面影响.
- 调查骨影响对于患者安全至关重要.
研究的目的:
- 评估在Graves轨道病治疗期间的骨周转,质量和结构.
- 确定这种治疗方案对骨健康的安全性.
主要方法:
- 32名患有格雷夫斯轨道病的患者接受了12周的静脉注射甲基prednisolone.
- 骨周转率,甲状腺功能,骨矿物质密度 (BMD) 和骨结构在不同的时间点被测量.
- 使用双X射线吸收度和高分辨率的外围定量计算机断层扫描.
主要成果:
- 在整个研究过程中,骨周转和三甲状腺素水平下降.
- 在第24周,皮层体积BMD和大腿部和部总骨矿物质密度显著增加.
- 皮层孔隙性显著减少,表明骨结构有所改善.
结论:
- 在12周的时间里,甲基普雷迪尼索隆治疗导致骨周转率和皮质多孔性降低.
- 在24周的随访期间,骨矿物质密度增加.
- 静脉注射甲基prednisolone似乎是一个安全的治疗Graves的轨道病有关骨健康.
更多相关视频
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
08:07Preparation of Herbal Medicine: Er-Xian Decoction and Er-Xian-containing Serum for In Vivo and In Vitro Experiments
Published on: May 31, 2017
相关概念视频
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...